Shigeru Miki

<i>In Vitro</i>Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor

Masanori Kobayashi, Tomokazu Yoshinaga, Takahiro Seki et al. · Antimicrobial Agents and Chemotherapy · 2010 · 371 citations · Full text

Neurovirology, Drug Discovery, Medicine +14

S-1153 Inhibits Replication of Known Drug-Resistant Strains of Human Immunodeficiency Virus Type 1

Tamio Fujiwara, Akihiko Sato, Mohamed A. El‐Farrash et al. · Antimicrobial Agents and Chemotherapy · 1998 · 124 citations · Full text

Known Drug-resistant Strains, Immunology, Molecular Biology +16

Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants

Masanori Kobayashi, Koichiro Nakahara, Takahiro Seki et al. · Antiviral Research · 2008 · 104 citations

Human Retrovirus, Immunology, Antiviral Drug Development +8

Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection

Tomokazu Yoshinaga, Masanori Kobayashi, Takahiro Seki et al. · Antimicrobial Agents and Chemotherapy · 2014 · 95 citations · Full text

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral

Edward P. Garvey, Brian A. Johns, Margaret Gartland et al. · Antimicrobial Agents and Chemotherapy · 2007 · 74 citations · Full text

Naphthyridinone Gsk364735, Medicine, Human Retrovirus +13